Neurotrope Inc (NASDAQ:NTRP)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - NTRP

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - NTRP

  • Market Cap$26.390m
  • SymbolNASDAQ:NTRP
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS64129T2078

Company Profile

Neurotrope Inc is a biopharmaceutical company. The company is principally focused on developing a product platform based on a drug candidate called bryostatin for the treatment of Alzheimer's disease ("AD"), which is in the clinical testing stage. It is also developing bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C, which are in pre-clinical testing.Neurotrope Inc is biopharmaceutical company with product candidates in pre-clinical and clinical development. It is engaged in developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease.

Latest NTRP news

Currently there for this company. Visit our news hub for other news .